Price D, Ryan D, Burden A, Von Ziegenweidt J, Gould S, Freeman D, Gruffydd-Jones K, Copland A, Godley C, Chisholm A, Thomas M Clin Transl Allergy 2013; 3(1): 37. [PubMed][Full Text]
Read moreUsing fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Lead Author: David Price Published: 7/11/13 Journal: Clinical & Translational Allergy
Read moreClinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A, Brockman J, King C, Papi A Prim Care Respir J 2013; 22(4): 439-48. [PubMed][Full Text]
Read moreThe arch conference declaration. Helping to further the science of pragmatic research
Martin R, Chisholm A, Price D Ann Am Thorac Soc 2014; 11(Suppl 2): S83-4. [PubMed][Full Text]
Read moreReal-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
Price D, Thomas M, Haughney J, Lewis RA, Burden A, von Ziegenweidt J, Chisholm A, Hillyer EV, Corrigan CJ Respir Med 2013; 107(7): 987-1000. [PubMed][Full Text]
Read moreReal-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
Lead Author: David Price et al Published: 1/5/13 Journal: Respiratory Medicine
Read moreCharacteristics of patients preferring once-daily controller therapy for asthma and chronic obstructive pulmonary disease: retrospective observational study
Lead Author: David Price et al Published: 4/3/13 Journal: Primary Care Respiratory Journal
Read moreA UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Price D, Asukai Y, Ananthapavan J, Malcolm B, Radwan A, Keyzor I Appl Health Econ Health Policy 2013; 11(3): 259-74. [PubMed][Full Text]
Read moreEffect of inhaled corticosteroid therapy step-down and dosing regimen on measures of asthma control
Price D, Chisholm A, Hillyer EV, Burden A, von Ziegenweidt J, Svedsater H, Dale P J Aller Ther 2013; 4(1): 126.
Read moreCharacteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study
Price D, Lee A, Sims EJ, Kemp L, Hillyer EV, Chisholm A, von Ziegenweidt J, Williams, A Prim Care Respir J 2013; 22(2): 161-8. [PubMed][Full Text]
Read moreEffect of inhaled corticosteroid therapy step-down and dosing regimen on measures of asthma control
Lead Author: David Price et al Published: 19/12/12 Journal: Journal of Allergy & Therapy
Read moreReal-life asthma strategies: the missing piece in the jigsaw
Price D, Bjermer L, Haughney J, Roche N, Bousquet J, Hillyer EV, Chisholm A Treatment Strategies – Respiratory 2012; 3(2): 37–46.
Read more